|4Aug 15, 5:44 PM ET

Cook Jennifer E. 4

4 · Jazz Pharmaceuticals plc · Filed Aug 15, 2023

Insider Transaction Report

Form 4
Period: 2023-08-11
Transactions
  • Award

    Ordinary Shares

    2023-08-11+3,0758,546 total
  • Sale

    Ordinary Shares

    2023-08-14$138.16/sh1,241$171,4547,305 total
Footnotes (3)
  • [F1]Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 3, 2024.
  • [F2]Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F3]Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $137.69 to $138.16. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT